Drug Profile
CK 53
Latest Information Update: 01 May 2002
Price :
$50
*
At a glance
- Originator National Defense Medical Center
- Class Antiplatelets
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 02 Mar 1995 Preclinical development for Thrombosis in Taiwan (Unknown route)